These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10993898)

  • 1. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
    Fanayan S; Firth SM; Butt AJ; Baxter RC
    J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
    Kuemmerle JF; Murthy KS; Bowers JG
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G795-802. PubMed ID: 15178549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells.
    Koli KM; Ramsey TT; Ko Y; Dugger TC; Brattain MG; Arteaga CL
    J Biol Chem; 1997 Mar; 272(13):8296-302. PubMed ID: 9079651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
    Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A
    Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
    Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
    J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-beta- and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures.
    Kamanga-Sollo E; Pampusch MS; White ME; Dayton WR
    J Cell Physiol; 2003 Nov; 197(2):225-31. PubMed ID: 14502562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
    Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
    J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
    O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
    J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
    Runyan CE; Schnaper HW; Poncelet AC
    J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.